History of elevated PSA. Evaluate for disease. 15 minutes of direct patient contact was spent counseling the patient about the improved image quality when using an endorectal coil. The patient declined coil placement.PELVIS:PROSTATE:Prostate Size: 5.4 x 4.7 x 4.1 cm (transverse by AP by cc)Peripheral Zone: There is typical heterogeneous appearance of the peripheral zone gland parenchyma. Within the mid to lower aspect of the left apex there is a geographic area of lower T2 signal which abuts the lateral aspect of the capsule and cranially towards the mid gland. This measures 1.1 x 1.3 x 1.0 cm (series 1001 image 16). This is associated with slightly asymmetric early arterial enhancement relative to the rest of the peripheral zone (series 2101 image 1216). There is associated restricted diffusion (series 804 image 284). Appearance is compatible with tumor.Slightly more cranial to this lesion there is an additional small focus of signal abnormality in the mid gland which measures 5 x 5 mm (series 1001 image 18). This may represent an additional small focus of tumor.There is a nonenhancing cystic focus in the posterior aspect of the right peripheral zone which measures 7 mm in maximum diameter and likely represents a retention cyst.Central Gland: Expected nodular appearance of benign prostatic hypertrophy.Seminal Vesicles: Mild dilatation of the seminal vesicles. No evidence of tumor involvement.Extracapsular Extension: No evidence of extracapsular extension.BLADDER: No significant abnormality noted.LYMPH NODES: No pelvic or abdominal lymphadenopathy.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Focus of abnormal signal in the left peripheral zone apex measuring 1.3 cm in maximum dimension compatible with tumor. There is an additional small focus of abnormal signal in the mid gland superior to the dominant lesion which measures 5 mm in maximum dimension. No specific evidence of extracapsular extension or metastatic disease.